1α,25-Dihydroxyvitamin D
3 (1,25-D
3, calcitriol) is the most active form of vitamin D and has antineoplastic activity at supraphysiologic doses in several cancers both in vitro and in vivo.
1 x 1 Deeb, KK, Trump, DL, and Johnson, CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007; 7: 684–700 Crossref | PubMed | Scopus (858) | Google Scholar See all References At these doses, 1,25-D
3 is associated with antiproliferative activity,
2 x 2 Hershberger, PA, Modzelewski, RA, Shurin, ZR, Rueger, RM, Trump, DL, and Johnson, CS. 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res. 1999; 59: 2644–2649 PubMed | Google Scholar See all References
, 3 x 3 Koshizuka, K, Koike, M, Asou, H et al. Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo. Breast Cancer Res Treat. 1999; 53: 113–120 Crossref | PubMed | Scopus (62) | Google Scholar See all References
, 4 x 4 McElwain, MC, Modzelewski, RA, Yu, WD, Russell, DM, and Johnson, CS. Vitamin D: an antiproliferative agent with potential for therapy of squamous cell carcinoma. Am J Otolaryngol. 1997; 18: 293–298 Abstract | Full Text PDF | PubMed | Scopus (27) | Google Scholar See all References induction of cell differentiation,
5 x 5 Liu, M, Lee, MH, Cohen, M, Bommakanti, M, and Freedman, LP. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 1996; 10: 142–153 Crossref | PubMed | Scopus (776) | Google Scholar See all References cell cycle arrest,
6 x 6 Yee, SW, Campbell, MJ, and Simons, C. Inhibition of Vitamin D3 metabolism enhances VDR signalling in androgen-independent prostate cancer cells. J Steroid Biochem Mol Biol. 2006; 98: 228–235 Crossref | PubMed | Scopus (36) | Google Scholar See all References apoptosis,
7 x 7 Bernardi, RJ, Trump, DL, Yu, WD, McGuire, TF, Hershberger, PA, and Johnson, CS. Combination of 1alpha,25-dihydroxyvitamin D3 with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res. 2001; 7: 4164–4173 PubMed | Google Scholar See all References ,
8 x 8 McGuire, TF, Trump, DL, and Johnson, CS. Vitamin D3-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem. 2001; 276: 26365–26373 Crossref | PubMed | Scopus (116) | Google Scholar See all References and inhibition of angiogenesis.
9 x 9 Nakagawa, K, Sasaki, Y, Kato, S, Kubodera, N, and Okano, T. 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis. 2005; 26: 1044–1054 Crossref | PubMed | Scopus (116) | Google Scholar See all References Antiproliferative activity is mediated through the vitamin D receptor (VDR), which is not only found in classic target organs (intestinal tract, kidney and bone) but also in many other epithelial and mesenchymal cells of tissues, such as lung, prostate, and breast. The evidence for a possible role of the vitamin D pathway in lung cancer comes largely from in vitro or in vivo studies. Higashimoto et al.
10 x 10 Higashimoto, Y, Ohata, M, Nishio, K et al. 1alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line. Anticancer Res. 1996; 16: 2653–2659 PubMed | Google Scholar See all References reported that 1,25-D
3 inhibited the growth of lung cancer cell lines and affects cell cycle regulation in squamous cell carcinoma models.
11 x 11 Light, BW, Yu, WD, McElwain, MC, Russell, DM, Trump, DL, and Johnson, CS. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res. 1997; 57: 3759–3764 PubMed | Google Scholar See all References ,
12 x 12 Hershberger, PA, McGuire, TF, Yu, WD et al. Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. Mol Cancer Ther. 2002; 1: 821–829 PubMed | Google Scholar See all References 1,25-D
3 has been shown to inhibit lung tumor growth and lung metastases in mouse models.
13 x 13 Young, MR, Ihm, J, Lozano, Y, Wright, MA, and Prechel, MM. Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol Immunother. 1995; 41: 37–45 Crossref | PubMed | Scopus (68) | Google Scholar See all References ,
14 x 14 Nakagawa, K, Kawaura, A, Kato, S, Takeda, E, and Okano, T. 1 alpha,25-Dihydroxyvitamin D3 is a preventive factor in the metastasis of lung cancer. Carcinogenesis. 2005; 26: 429–440 Crossref | PubMed | Scopus (105) | Google Scholar See all References The antiproliferative effect of 1,25-D
3 is related to G
1 cell cycle arrest and is directly and inversely proportional to the
VDR15 x 15 Kim, SH, Chen, G, King, AN et al. Characterization of vitamin D receptor (VDR) in lung adenocarcinoma. Lung Cancer. 2012; 77: 265–271 Abstract | Full Text | Full Text PDF | PubMed | Scopus (37) | Google Scholar See all References and
CYP24A1 expression, respectively.
16 x 16 Chen, G, Kim, SH, King, AN et al. CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma. Clin Cancer Res. 2011; 17: 817–826 Crossref | PubMed | Scopus (65) | Google Scholar See all References